Clive has over 30 years’ experience of supporting clients with their business change and technology contracts, working for Pinsent Masons.
Working through the difficult situation in which we found ourselves made for a challenging and stressful period for many people on the [client] team. However, I am very aware that having Pinsent Masons alongside us made this experience much easier that it might have been; we have been very fortunate to benefit from your expert guidance, from your kindness and from your consistent support.
Client CEO - 2023
This has been the culmination of many years of hard work, and indeed a moment that many thought would never happen. Both of you and the wider Pinsents team have been instrumental throughout the journey, and I wanted to thank you for all you have done, and continue to do for us, and for me. We wouldn't have got to this point without you. @Programme Director
- Programme Director Financial services infrastructure project
I would just like to recognise the fantastic support you have given me and the team here at C&CCC. I have really enjoyed working with you all and if I ever need similar services again or if someone is in need of a recommendation, I will wholeheartedly recommend you. @CEO
- CEO Cheque
UK government plans to revamp holiday pay calculation for part-year workers
Senior Practice Development Lawyer
Tadeusz is responsible for a range of practice development activities within our Competition, EU & Trade team, supporting the team’s EU and UK competition law work. This includes delivering training, monitoring legal developments, sharing knowledge, developing best practices and resources, and facilitating innovation.
Partner, Head of Retail & Consumer
Tom specialises in private equity.
Tracey is an intellectual property litigator in the life sciences sector, who studied Natural Sciences specialising in pathology. Tracey's principal expertise is in leading high-profile, multi-jurisdictional patent cases where she coordinates litigation strategy across Europe and worldwide, acting for both innovator and generic/biosimilar clients.